...
首页> 外文期刊>American Journal of Physiology >MicroRNA-29c in urinary exosome/microvesicle as a biomarker of renal fibrosis.
【24h】

MicroRNA-29c in urinary exosome/microvesicle as a biomarker of renal fibrosis.

机译:泌尿外泌体/微泡中的MicroRNA-29c作为肾纤维化的生物标志物。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Micro (mi)RNAs are frequently dysregulated in the development of renal fibrosis. Exosomes are small membrane vesicles that could be isolated from urine secreted from all nephron segments. Here we sought to observe for the first time whether miRNA in urine exosome could serve as a potential biomarker of renal fibrosis. Urine samples were collected from 32 chronic kidney disease (CKD) patients who underwent kidney biopsy and 7 controls. Exosome was isolated and confirmed by immunogold staining of exosome marker. Members of miR-29, miR-200, and RNU6B as endogenous control were detected by RT quantitative PCR. Electronic microscopy verified a typical shape of exosome with average size of 65.1 nm and labeled it with anti-CD9 and anti-aquaporin 2 antibody. Members of miR-29 and miR-200 are readily measured with reduced levels compared with controls (P < 0.05) and can robustly distinguish CKD from controls [area under the curve (AUC) varied from 0.902 to 1 by receiver operating characteristics analysis]. miR-29c correlated with both estimated glomerular filtration rate (r — 0.362; P < 0.05) and degree of tubulointerstitial fibrosis (r = -0.359; P < 0.05) for CKD patients. Moreover, miRNA in exosome was decreased in mild fibrosis group compared with moderated to severe group. miR-29a and miR-29c could predict degree of tubulointerstitial fibrosis with AUC of 0.883 and 0.738 (P < 0.05). The sensitivity and specificity for distinguishing mild from moderate to severe fibrosis were 93.8 and 81.3% with the use of miR-29a and 68.8 and 81.3% for miR-29c. Overall, miR-29c in urinary exosome correlates with both renal function and degree of histological fibrosis, suggesting it as a novel, noninvasive marker for renal fibrosis.
机译:微小(mi)RNA在肾纤维化的发展中经常失调。外泌体是小的膜囊泡,可以从所有肾单位段分泌的尿液中分离出来。在这里,我们试图首次观察尿液外泌体中的miRNA是否可以作为肾纤维化的潜在生物标记。从32位接受肾脏活检的慢性肾脏病(CKD)患者和7位对照中收集尿液样本。分离外泌体并通过外泌体标记的免疫金染色确认。通过RT定量PCR检测miR-29,miR-200和RNU6B成员作为内源性对照。电子显微镜检查证实了外泌体的典型形状,平均大小为65.1 nm,并用抗CD9和抗水通道蛋白2抗体对其进行了标记。与对照组相比,miR-29和miR-200的成员很容易以降低的水平进行测量(P <0.05),并且可以从对照组中强有力地区分CKD [曲线下面积(AUC)通过接收器工作特性分析从0.902变到1]。对于CKD患者,miR-29c与估计的肾小球滤过率(r_0.362; P <0.05)和肾小管间质纤维化程度(r = -0.359; P <0.05)相关。此外,轻度纤维化组与中度至重度组相比,外泌体中的miRNA降低。 miR-29a和miR-29c可以预测肾小管间质纤维化程度,AUC为0.883和0.738(P <0.05)。使用miR-29a区分轻度至中度至重度纤维化的敏感性和特异性分别为93.8和81.3%,而miR-29c分别为68.8和81.3%。总体而言,尿液外泌体中的miR-29c与肾脏功能和组织学纤维化程度相关,这表明它是肾纤维化的一种新型,非侵入性标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号